
We are delighted to announce the launch of Vetted Investments, our specialist investment syndicate connecting experienced investors with carefully selected opportunities across medtech, digital health and healthcare innovation.
Health technology offers extraordinary potential for both commercial and societal impact—but identifying the most promising opportunities requires more than traditional investment analysis. Understanding the science, clinical need, regulatory pathway, adoption potential and route to commercial scale requires specialist expertise.
That is why we created Vetted Investments.
Through our partnership with R8ER, potential investments are evaluated through a rigorous, expert-led assessment process. For each opportunity, we bring together a tailored panel of leading clinicians, academics, industry specialists, regulatory experts, commercial leaders and investors to examine the company and its technology from multiple perspectives.
Companies that progress through this process and further investment due diligence can then be presented to the Vetted Investments Syndicate, giving eligible investors access to selected private health-tech investment opportunities on a deal-by-deal basis.
There is no obligation to invest. Members can consider each opportunity independently and participate in those that match their own interests and investment objectives.
But our ambition goes beyond creating another investment syndicate.
We want to build a community around better-informed health-tech investment—connecting outstanding innovators, world-class healthcare expertise and experienced investment capital to help promising technologies move from innovation towards adoption and scale.
Expert-reviewed. Investor-led. Focused on the future of healthcare.
Explore Vetted Investments to learn more about our approach and current focus.
Investors interested in Vetted Investments or our wider investment activities can also register their interest with us.
Click here to Register your interest and receive more information.
Participation is restricted to eligible investors. Investments in private companies involve risk, including the potential loss of invested capital. Nothing in this announcement constitutes investment advice or an offer or solicitation to invest.